Package Leaflets

Every medicine includes a Package Leaflet which provides information on using the medicine safely to patients, carers and other members of the public. 

The IMB is currently preparing for the publication of Package Leaflets for new medicines as they are licensed nationally by the IMB or through the European mutual-recognition and decentralised procedures. In addition, for currently authorised medicines the Package Leaflet will become available in the future in cases where certain changes to the leaflet are approved by the IMB. 

For product information, including the Package Leaflet, on medicines that are licensed centrally by the European Commission, please consult the European Medicines Agency website